A.D.S. Diagnostics Ltd.

BSE: ADSDIAG523031

Healthcare
Healthcare Service Provider

Share price

—

52W high: —
52W low: —
Off 52W high: —
1M return: —
3M return: —
6M return: —
1Y return: —
20D avg volume: —
50 DMA: —
200 DMA: —

Key ratios Standalone

Market cap: ₹2.55 Cr
Current price: —
52W high / low: — / —
Face value: ₹10.00
P/E: 2.61
P/B: 0.38
EPS (TTM): ₹4.35
Book value / share: ₹29.90
ROE: 14.55%
ROCE: 27.70%
Operating margin: 4.75%
Net margin: 0.98%
Debt / equity: 0.42
Net debt: ₹1.83 Cr
Interest cover: 3.38
Dividend yield: —
Dividend / share (TTM): ₹1.20
Payout: 27.59%
Cash conversion cycle: 125.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	3.28	4.00	5.43	14.66	4.27	3.34	—
	0.23	0.04	0.03	-0.07	0.13	0.03	—
	3.48	3.87	5.20	13.77	4.20	3.26	—
	0.47	1.91	3.02	9.42	2.22	1.05	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.74	0.85	0.84	0.85	0.68	0.73	—
	0.10	0.13	0.18	0.18	0.12	0.06	—
	0.01	-0.02	0.02	0.03	0.03	0.03	—
	2.14	0.99	1.15	3.30	1.15	1.38	—
	0.04	0.17	0.26	0.82	0.20	0.12	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.04	0.17	0.26	0.82	0.20	0.12	—
	0.01	0.05	0.06	0.21	0.05	0.05	—
	0.03	0.12	0.20	0.61	0.15	0.07	—
	0.15	0.53	0.90	2.77	0.67	0.32	—
Key metrics
	0.15	0.28	0.46	1.03	0.35	0.21	—
	4.60%	7.00%	8.50%	7.00%	8.20%	6.30%	—
	0.90%	3.00%	3.70%	4.20%	3.50%	2.10%	—
	—	4.00%	—	14.00%	—	2.70%	—
	-23.20%	19.80%	—	—	—	—	—
	-80.00%	71.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	27.37	28.36	16.00	—
	0.23	0.13	0.13	—
	26.32	27.04	15.05	—
	14.82	16.58	7.00	—
	0.00	0.00	0.00	—
	3.28	3.22	2.83	—
	0.59	0.61	0.30	—
	0.04	0.06	0.15	—
	7.58	6.58	4.76	—
	1.29	1.45	1.08	—
	0.00	0.00	0.00	—
	1.29	1.45	1.08	—
	0.33	0.38	0.28	—
	0.96	1.07	0.81	—
	4.35	4.88	3.67	—
Key metrics
	1.92	2.12	1.53	—
	7.01%	7.50%	9.60%	—
	3.51%	3.80%	5.10%	—
	—	27.70%	20.90%	—
	—	77.20%	—	—
	—	32.10%	—	—
	—	-0.11	0.57	—
	—	-0.04	0.96	—
	—	0.42	0.35	—
	—	1.83	1.02	—
	—	125.7	136.0	—
Balance sheet
	—	22.86	19.15	—
	—	21.46	18.33	—
	—	1.27	1.29	—
	—	4.97	4.30	—
	—	12.68	8.99	—
	—	1.46	2.77	—
	—	0.28	0.26	—
	—	7.89	7.33	—
	—	15.42	12.56	—
	—	3.10	2.31	—
	—	3.10	2.31	—
	—	0.00	0.00	—
	—	7.44	6.59	—
Cash flow
	—	-0.04	0.78	—
	—	0.06	-0.12	—
	—	-0.04	-0.34	—
	—	0.07	0.21	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 45.39%

Holder	Type	Holding	Previous	Change
DR MRS. VERSHA SEHGAL	Promoter	25.19%	—	—
DR VIVEK SEHGAL	Promoter	9.41%	—	—
DR GAUTAM SEHGAL	Promoter	5.96%	—	—
AD SEHGAL & SONS	Promoter	3.92%	—	—
BANK OF INDIA	Public	3.07%	—	—
MRS. RADHIKA SEHGAL	Promoter	0.91%	—	—
DIRECTOR RELATIVES	Public	0.56%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY (TTM)	Profit YoY (TTM)	1Y return
Dr. Lal Pathlabs Limited	32,834	1,956.15	60.03	25.70%	+14.29%	+5.38%	-37.55%
Vijaya Diagnostic Centre Limited	15,215	1,477.25	81.07	19.20%	+20.18%	+24.26%	+45.46%
Metropolis Healthcare Limited	11,668	562.60	57.51	15.70%	—	—	-72.18%
Thyrocare Technologies Limited	8,701	546.65	49.47	33.60%	+21.09%	+67.13%	-53.82%
Nephrocare Health Services Limited	6,669	663.20	—	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,850	355.30	52.76	14.70%	—	—	+18.91%
Krsnaa Diagnostics Limited	1,800	554.95	18.47	10.60%	—	—	-27.91%
3B BlackBio Dx Limited	1,395	1,625.10	24.79	22.60%	—	—	+15.96%
ONE GLOBAL SERVICE PROVIDER LIMITED S	1,045	534.60	14.13	65.70%	—	—	+90.66%
HEALTH X PLATFORM LIMITED	910	285.95	-34.91	—	—	—	-9.31%
Gaudium IVF and Women Health Limited	830	114.00	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited	148	143.34	—	15.70%	—	—	+131.45%
Choksi Laboratories Ltd. S	132	188.90	60.94	12.30%	—	—	-1.59%
STAR IMAGING AND PATH LAB LIMITED	131	75.25	—	22.60%	—	—	-43.74%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	103	68.50	49.64	11.20%	—	—	—
BANDARAM PHARMA PACKTECH LIMITED	36	19.94	29.89	4.70%	—	—	-36.70%
N.G.Industries Ltd. S	35	105.00	18.26	6.30%	—	—	-29.41%
Sharma East India Hospitals And Res S	34	85.30	23.63	14.20%	—	—	-46.59%
Deccan Health Care Limited	29	11.87	10.94	3.20%	—	—	-40.20%
Chennai Meenakshi Multispeciality Hospital Ltd. S	28	37.00	-67.27	-2.80%	—	—	-15.58%
Tejnaksh Healthcare Limited	26	13.00	21.47	5.90%	—	—	-28.61%
SAMSRITA LABS LIMITED	26	11.51	-3.21	-73.40%	—	—	-39.55%
Transgene Biotek Ltd.	17	2.53	-11.92	-0.50%	—	—	-36.91%
Dhanvantri Jeevan Rekha Ltd. S	10	24.76	17.69	3.40%	—	—	-16.35%
FAMILY CARE HOSPITALS LIMITED S	10	1.86	-1.19	-85.60%	—	—	-61.49%
A.D.S. Diagnostics Ltd. S	3	—	2.61	27.70%	—	—	—

Filings & corporate actions

Recent announcements

List of Proceedings of Annual General Meeting of the Company held today i.e. September 29, 2026 is attached.29 Sep 2026 · AGM/EGM / AGM
Pursuant to regulation 42 of SEBI please find enclosed the date of record date for determining the record date for payment of divided to shareholders and date of book closure and determining ....22 Sep 2026 · Company Update / General
Pursuant to Regulation 42 of SBEI(LODR), 2015 and in continuation of our disclosure of even reference dated 04th September, 2026 regarding the 41st AGM, we hereby give advance notice that: 1. ....21 Sep 2026 · Company Update / General
NOTICE IS HEREBY GIVEN that the 41st Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Tuesday, the 29th September, 2026, at 11:30 A.M. Through Video Conferencing ....4 Sep 2026 · Others / Reg. 34 (1) Annual Report
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....13 Aug 2026 · Board Meeting / Outcome of Board Meeting
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve The meeting of the Board ....4 Aug 2026 · Board Meeting / Board Meeting
ANNUAL SECRETARIAL COMPLIANCE REPORT29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....29 May 2026 · Board Meeting / Outcome of Board Meeting
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Board Meeting of ADS Diagnostic ....15 May 2026 · Board Meeting / Board Meeting
compliance under regulation 6(1) and 7(1) of sebi lodr regulations 201530 Apr 2026 · Company Update / Reg. 7(3) – Compliance Certificate (RTA & Compliance Officer)
compliance certificate regulation 40(9) of SEBI LODR REGULATIONS,201530 Apr 2026 · Company Update / Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI we wish to inform you that the Board of Directors (the ''Board'') of ADS Diagnostic Limited (''the Company'') ....13 Feb 2026 · Board Meeting / Outcome of Board Meeting
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Board meeting of ads diagnostic ....3 Feb 2026 · Board Meeting / Board Meeting
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....12 Nov 2025 · Board Meeting / Outcome of Board Meeting
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Notice is hereby given pursuant ....5 Nov 2025 · Board Meeting / Board Meeting
proceedings of 40th annual general meeting of ads diagnostic limited29 Sep 2025 · AGM/EGM / AGM
Pursuant to regulation 42 of Sebi, we wish to inform you that register of members and share transfer books will remain closed from 23.09.2025 to 29.09.2025. (booth days inclusive), the ....10 Sep 2025 · Corp. Action / Book Closure
NOTICE IS HEREBY GIVEN that the 40th Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Monday, the 29th September, 2025, at 11:30 A.M. Through Video Conferencing ....30 Aug 2025 · Others / Reg. 34 (1) Annual Report
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....12 Aug 2025 · Board Meeting / Outcome of Board Meeting
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Board meeting of ADS Diagnostic ....2 Aug 2025 · Board Meeting / Board Meeting
ADS DIAGNOSTIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Notice is hereby given pursuant ....2 Aug 2024 · Board Meeting / Board Meeting
Shri Narayan Lal Gayari appointed as company company secretary on 16-07-1996, since there is no change till date30 Jul 2024 · Company Update / Reg. 7(3) – Compliance Certificate (RTA & Compliance Officer)
Revised outcome19 Jul 2024 · Company Update / Revision of outcome
Revised outcome of board meeting, audited result along with audit report17 Jul 2024 · Result / Financial Results
Revised outcome result of board meeting as per email receive from bse on 26.06.202428 Jun 2024 · Company Update / Revision of outcome

Corporate actions

Purpose	Ex date	Record date	Payment date
Dividend - Rs. - 1.2000	25 Sep 2026	26 Sep 2026	—
Final Dividend - Rs. - 1.0000	19 Sep 2025	20 Sep 2025	—
Final Dividend - Rs. - 1.2000	30 Sep 2024	30 Sep 2024	—

Board meetings

13 Aug 2026 Board Meeting - Financial Results